Forbes magazine's Robert Langreth has an extensive interview with technology investor R.J. Kirk (above) of Radford, a guy he calls "the best biotech investor ever" here.Kirk has taken on a partner in order "to change the world," says Langreth.
Here's some of what Langreth says:
But Kirk says everything he has done in the past pales next to the potential of his latest project: Intrexon, a secretive research-stage company that is working on the hot new field of synthetic biology—basically genetic engineering on steroids. Kirk and his investment fund, Third Security, have poured $200 million into the closely held 180-person company based in Blacksburg, which has no drugs on the market.
“I’ve been a biotech investor for 27 years, and Intrexon is by far the best thing I’ve ever seen,” says Kirk, 56, who raises falcons and composes electronic music on a 7,200-acre cattle farm in rural Pulaski County, Va. He likens Intrexon to “the Google of the life sciences” and predicts that in a decade it could become “the largest, most significant company” in its burgeoning field.
(Forbes photo.)
No comments:
Post a Comment